







• This study investigates the potential of high mass accuracy MS (HRMS) to
provide the specificity currently associated with multiple reaction monitoring
in tandem mass spectrometry (MSMS) techniques for analysis of dried blood
spot (DBS) samples from patients.
• DBS are being widely investigated as a tool for micro- sampling to facili-
tate paediatric pharmacokinetic (PK) studies and for application in preclini-
cal, toxicokinetic and clinical studies.
• In HRMS analyses mass measurement is determined accurately to 1ppm
of the chosen mass.
• This m/z accuracy provides the specificity of the technique since for organic







• Mass (m/z) accuracy is available from either TOF or Orbitrap systems.
• Data collected per analysis is the total ionisation from the sample which is
subsequently “mined” for the corrected mass. The data can be re-interrogated
for other information subsequently.
• Quantitative DBS analysis has gained considerable interest in recent years
as it offers many advantages including simplicity of sample collection, storage
and sample transport.
• Some initial clinical data from DBS for the above drugs is reported.
Analyte extraction from dried blood spots (DBS)
• Blood spot samples were collected on Guthrie cards. The cards were pre-
treated with 1,4 dithiothreitol (DTT) for captopril. 
• The target drugs were solvent extracted from disks punched from the DBS
and analysed (Fig. 1).
LC-HRMS
Figure 1. Dried blood spot solvent extraction [1] Lawson G. et al. J Pharm. Pharmacol. 2009. 61(1 Suppl): A33.
[2] Patel P. et al. J Pharm. Pharmacol. 2009. 61(1 Suppl): A112.
[3] Patel P. et al. J Chromatogr. B 2010. 878(31): 3277-3282.
[4] Tanna S. & Lawson G. Anal. Methods 2011. DOI: 10.1039/C1AY05160A
METHODS
• Sigma Aldrich for donation of LC column
MS Conditions
• Agilent 6530 QTOF mass spectrometer, 1290 Infinity LC
• LC HRMS with TOF only used at m/z 276.1073 for atenolol, m/z 218.0845
for captopril, at m/z 195.0883 for caffeine and m/z 393.2072 for dexametha-
sone.
• Mass detectors used with electrospray interface and in positive ion mode.
CLINICAL APPLICATION OF DBS TECHNIQUE
• The TOF gave good data for therapeutic levels of atenolol, captopril, caf-
feine and dexamethasone and the method demonstrated good selectivity.
• The TOF recorded data may be subsequently re-interrogated for other ions
without the need to re-run the sample.
• Figure 4b demonstrates the ability of this methodology to monitor the up-
take of additives in food.
• The use of small volume blood samples makes the DBS approach
particularly appropriate for use in paediatric PK studies.
• This approach could also facilitate therapeutic drug monitoring.
• DBS sampling is simple and the method could be adapted to other drugs




Column Ascentis Express C18 100x2.1mm Ascentis Express C18 100x2.1mm
Column temperature 30˚C 40˚C
Flow rate 0.2 ml/min 0.5 ml/min
Mobile Phase A 0.1% Formic Acid in water 0.1% Formic Acid in water
Mobile Phase B 0.1% Formic Acid in ACN 0.1% Formic Acid in ACN
Gradient conditions 95:5 to 30:70 in 7 min 90:10 to 0:100 in 5 min
Injection volume 5 l 5 l 
Captopril Dexamethasone
Column Zorbax Ecplise C18 100x2.1mm Zorbax Ecplise C18 100x2.1mm
Column temperature 40˚C 40˚C
Flow rate 0.5 ml/min 0.5 ml/min
Mobile Phase A 0.1% Formic Acid in water 0.1% Formic Acid in water
Mobile Phase B 0.1% Formic Acid in MeOH 0.1% Formic Acid in ACN
Gradient conditions 80:20 to 0:100 in 5 min 70:30 to 30:70 in 5 min 
Injection volume 10 l 20l
Extraction efficiency (recovery)
Atenolol Caffeine Captopril Dexamethasone
Recovery (%) 96 ± 5 74 ± 6 90 ± 10 98 ± 6
Validation
• Showed good accuracy, precision and good linearity (R2 > 0.99).
• Minimum limits of quantification (LoQ S/N = 10) for target drug spiked
blood spot standards were as follows:
Atenolol Caffeine Captopril Dexamethasone
Range(ng/ml) 25-1500 100-250000 10-400 7.5-800
LoQ (ng/ml) 50 100 20 15
Selectivity
• Initial TOF data - the total ion chromatogram TIC (Fig. 2a and 3a) shows
the complexity of the data available for subsequent analysis. 
• Fig. 2b and 3b represents the extracted ion (EIC) data for m/z 218.0845
for captopril and for ion of m/z 195.0883 for caffeine. 
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Figure 2. TIC for captopril (a) and EIC for
captopril (b)
Figure 3. TIC for caffeine (a) and EIC for
caffeine (b)
Figure 5. DBS atenolol concentration-time profile for an adult volunteer administered a 100mg
atenolol tablet.
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• DBS concentration-time profiles for healthy volunteers following the inges-
tions of a 100mg caffeine tablet, 87.5mg caffeine drink and a 100mg atenolol
tablet were plotted.
Figure 4. DBS caffeine concentration-time profile for an adult volunteer administered (a) a 100mg
caffeine tablet and (b) a caffeine containing drink.
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